December 13-15, 2018

MedTech Impact 2018

Venetian/Palazzo Resort

Las Vegas, NV

(561) 893-8633

info@medtechimpact.com

Archives: Popups

Description.

Patrick Wayte

Patrick Wayte

Patrick Wayte is Senior Vice President of the AHA’s Center for Health Technology and Innovation. In this role he leads integrated digital health initiatives across the health continuum – with a focus on secondary prevention, healthcare transition, chronic care, and the use and application of the AHA’s science to digital platforms and technologies.

Patrick is also spear-heading new business models in digital health solutions and services with a particular emphasis in remote patient monitoring, tele-health, social connectivity, habit design and reward models, with the intent of achieving scalable and definable health outcomes.

Technology and channel partnerships are a key emphasis for this work and Patrick is lead for building and managing key channel and technology partners that will help the AHA move squarely into the lives of healthcare consumers (patients-caregivers-families), through a variety of different channels and mediums, with a focus on improving health understanding and outcomes – connecting people with their health, providers and with each other.

Prior to the American Heart Association and his role in healthcare, Patrick held positions in integrated marketing, strategy and new product development in the telecommunications and automotive industries with a focus on developing new lines of business through acquisition-partnerships-innovation.

Patrick lives with his family in Dallas and holds a degree in Economics from the University of California, San Diego and an MBA from Vanderbilt University.

Arshya Vahabzadeh

Arshya Vahabzadeh

Dr. Vahabzadeh is the Chief Medical Officer at Brain Power, a neuroscience-based company focused on the development of augmented reality and data-driven technologies for autism and behavioral health. He is also faculty at Massachusetts General Hospital and Harvard Medical School. Dr. Vahabzadeh has trained in psychiatry, child psychiatry, and family medicine. He is an expert on the application of wearable, immersive, and digital therapeutics for brain disorders. He has over 20 national and international awards in medical research, leadership, and innovation, and was the youngest Council Chairman at the American Psychiatric Association. He is a 40 under 40 healthcare innovator, and has been described as one of the future leaders in psychiatry. Dr. Vahabzadeh has numerous publications in authoritative texts, and has been quoted or written for many media outlets including CNN, USAToday, Huffington Post, Boston Globe, and Nature.  He is also the Innovation Officer at the Massachusetts General Hospital Psychiatry Academy, the largest educational and consulting service for mental health in nation. He is a senior mentor for Neurolaunch, the world’s first neuroscience startup accelerator.

Peter Tippett

Peter Tippett

Dr. Tippett is the CEO of HealthCelerate, former Verizon Chief Medical Officer, and a recognized leader in health IT transformation, information security and regulatory compliance. Among other technology start-ups, Tippett created the first commercial anti-virus product, which became Norton; founded TruSecure and CyberTrust and was Chairman of MD-IT.

 

Tippett was a member of the President’s Information Technology Advisory Committee (PITAC) under G.W. Bush, which drove Health IT transformation policy, and served with both the Clinton Health Matters and the NIH Precision Medicine initiatives.

 

He received the U.S. Chamber’s First Leadership in Health Care Award for his work to improve transparency and reward innovation through the modernization of the exchange of health information technology.  He has been recognized by industry publications including InfoWorld, as one of the 25 most influential CTOs in 2002.

 

Tippett was Research Assistant to R.B. Merrifield (Nobel Prize, 1984) and Stanford Moore (Nobel Prize, 1972) at Rockefeller University. He is a physician, board-certified in internal medicine with both Internal Medicine & Emergency Medicine practice history. He received both a PhD in biochemistry and an M.D., from Case Western Reserve University, and a bachelor’s degree in biology from Kalamazoo College.

Matthew Stoudt

Matthew Stoudt

Matthew Stoudt is a recovering investment banker, serial entrepreneur and the CEO and Co-Founder of appliedVR, the leading therapeutic VR platform in the US. appliedVR delivers non-pharmacological therapeutic alternatives to patients both in hospitals and at home via its VR Pharmacy. The company is partnered with 10 of the top 20 ranked hospitals (including the Mayo Clinic, Cedars-Sinai and NY-Presbyterian) and 3 of the top 10 ranked pediatric hospitals (including Boston Children’s Hospital) and is deployed in over 50 health care systems across the US. appliedVR was selected as the only therapeutic VR platform by Anthem as part of an innovative state Medicaid program.

 

Prior to founding appliedVR, Matthew founded and built out the largest digital out of home media platform in the US, exiting to Verifone in 2014; launched multiple successful businesses as an Entrepreneur-in-Residence at McDonald’s Corporation; and began his career in investment banking and private equity.

 

Matthew earned his MBA at Kellogg Graduate School of Business graduating with honors and his BA from Northwestern University.

 

Matthew is passionate about making a difference and brings that passion to leveraging the unique attributes of VR to drive positive behavior change and solve some of health care’s most intractable problems.

 

Carrie Shaw

Carrie Shaw

Carrie Shaw is passionate about the art and science of human health.

She’s turned that passion into a company, Embodied Labs, that is dedicated to teaching the health care providers, caregivers, and patients about human health through virtual reality storytelling. Embodied Labs envisions a world where healthcare providers and caregivers are empowered to provide better quality care to vulnerable patient populations by better understanding their first-person experiences.

Carrie is no stranger to delivering healthcare information in unique ways. Following her graduation from the University of North Carolina at Chapel Hill with a B.S. in Public Health, Carrie joined the Peace Corps as a Health Education volunteer in the Dominican Republic, where she taught reproductive health to youth and worked as a medical translator. After serving in the Peace Corps, Carrie became a caregiver for her mother, who had early-onset Alzheimer’s disease, and wondered, “If I could somehow step into my mother’s shoes and learn about life with AD through her eyes, would that help me become a better and more empathetic caregiver?” That question, along with lasting lessons of her service in the Peace Corps, drove her to pursue her Masters of Science in Biomedical Visualization at the University of Illinois Chicago, where she met her fellow Embodied Labs co-founders.

Embodied Labs’ work has been featured in Forbes, The History Channel, and The Journal of the American Medical Association, and the company was recently named one of five finalists in US Department of Education’s Ed Sim Challenge.

 

Michael Nova

Michael Nova

Dr. Nova is currently the Chief Innovation Officer of Pathway Genomics, and was a founding team member of the company. He is the inventor of the Pathway-IBM/Watson Machine Learning A.I. mobile application: Panorama/OME; and the entire Wellness (Pathway FIT/Healthy Weight, SkinFIT), Cardiac and Mental Health line of genetic testing products for Pathway. Dr Nova has executed major corporate alliances with companies such as Medco/ESI, PepsiCo, DASA (Brazil), Biogenetika (Brazil), Achibadem (Turkey), IHH/Parkway (Singapore), IBM, Florida Hospital Group, Equinox Health, and many others. His scientific career began as a research associate at the Salk Institute in the laboratory of Nobel Laureate Roger Guillemin, where he studied the genetics and proteomics of human growth factors and cancers. Michael was previously the founder and CEO of Discovery Partners Inc. (Nasdaq: DPII), which completed a successful $150M IPO and marketed wireless drug discovery technology and radiofrequency combinatorial chemistry to large pharmaceutical companies. Intellectual property developed by Dr. Nova at DPII included the original “barcode on bead” patents used by many diagnostic and DNA companies. He then founded the wireless sensory network company Graviton, where he was responsible for raising $60 million in capital from venture groups such as Kleiner Perkins, InQtel and large corporations such as Motorola and Qualcomm. Dr. Nova is also the 2005 World Economic Forum (WEF) Technology Pioneer Award Winner; and the physician of record on the first person ever to have their entire genome sequenced by Illumina (2009).

 

He is a member of the IBM Watson Advisory Board, the Metagenics Scientific Advisory Board, the Salk Institute NeuroAI group, and the Longevity Org Advisory Board.

 

Dr. Nova has over 30 issued, and 45 pending patents; and he has numerous publications in peer-reviewed journals. With degree’s in Biochemistry, Physics/Computer Science, and Medicine, Dr. Nova is a Board-certified Dermatologist and Dermatopathologist licensed in California. In his minimal spare time, Michael likes to surf big waves in Indonesia and Mexico, and he also helped build a WHO-sanctioned basic care clinic in the Fijian town of Nabila.

Arlen Meyers

Arlen Meyers

Arlen Meyers, MD, MRA is a professor emeritus of otolaryngology, dentistry, and engineering at the University of Colorado School of Medicine and the Colorado School of Public Health, serves as the Chief Medical Officer with BridgeHealth and Cliexa, and is President and CEO of the Society of Physician Entrepreneurs (www.sopenet.org). He is an associate editor of the Journal of Commercial Biotechnology and Technology Transfer and Entrepreneurship and Editor-in-Chief of Medscape Reference: Otolaryngology-Head and Neck Surgery; is a faculty member at the University of Colorado Denver Graduate School and Direct the Program in Biomedical Entrepreneurship at the Jabs Center for Entrepreneurship at the University of Colorado Denver Business School, and

Dr. Meyers’ primary research centers around biomedical and health innovation and entrepreneurship and life science technology commercialization. He consults with companies, governments, colleges and universities around the world seeking expertise and contacts in the areas of bio entrepreneurship, bioscience, healthcare, healthcare IT, medical tourism — nationally and internationally, new product development, product design, and financing new ventures.

He is a former Harvard-Macy fellow; in 2010 he completed a Fulbright at Kings Business, the commercialization office of technology transfer at Kings College in London. His publications this year include Building the Case for Biotechnology, Optical Detection of Cancer, and The Life Science Innovation Roadmap.

Sean McNamara

Sean McNamara

Sean McNamara, Manager of Health Partnerships at Garmin has spent the past few years in the healthcare and digital engagement platforms space.  In his current role, Sean is responsible for managing partnerships for Garmin Health in the payer, provider, pharmaceutical, population health and clinical trials industries.  Prior to managing Health Partnerships at Garmin, Sean has held leadership sales and marketing roles at healthcare engagement companies and consulting firms.   

Nikhil Krishnan

Nikhil Krishnan

Nikhil is a research analyst at CB Insights. He focuses on Healthcare, Consumer Packaged Goods, Industrials, and VC Trends. Published research and data analysis have been featured in The New York Times, Wall Street Journal, Financial Times, Bloomberg, and CNBC, among other major media outlets.

Scott Kaiser

Scott Kaiser

Scott Kaiser, MD, is a practicing geriatrician and Chief Innovation Officer at MPTF (Motion Picture & Television Fund), which provides services, support and assistance to the entertainment industry community.  In this role, Dr. Kaiser leads efforts to improve population health and well-being through social and community-based interventions.  A graduate of the Keck School of Medicine of USC, Dr. Kaiser trained within the Lawrence Family Medicine Residency, Harvard Geriatric Medicine Fellowship, and UCLA Health Services Research Fellowship—where he served as a Health Media Fellow.  Dr. Kaiser leverages his expertise to tirelessly advocate for the improvement of aging services and geriatric care.  He believes in looking beyond “healthcare” to meet people where they are and where health happens: in their daily lives, with their friends and families, in their communities.